Speakers
   --------

   N/A

   The resulting applications of newly developed whole-genome scanning
   technologies have catalyzed the appreciation of copy number variation
   ( CNV ) in the genomic community. Studies linking insertions,
   deletions, and inversions to disease etiology continue to multiply. As
   genome-wide scanning techniques become more widely used in diagnostic
   laboratories, the major challenge is how to accurately interpret which
   variations are pathogenic in nature and which are benign. Cambridge
   Healthtech Institute’s Second Annual Comprehending Copy Number
   Variation addresses current CNV challenges and examines the latest
   results with an international assembly of experts.